Floyd Ruffin’s appeal arising out of the Deepwater Horizon cleanup underscores the evidentiary demands that federal courts impose on toxic-tort plaintiffs who attempt to link alleged chemical exposure to a later cancer diagnosis. In a substituted opinion issued after denial of rehearing en banc, the U.S. Court of Appeals for the Fifth Circuit affirmed the exclusion of the plaintiff’s causation expert and the resulting summary judgment for BP. The decision addresses a recurring Daubert dispute in oil-spill “BELO” litigation: whether general causation must be supported by testimony identifying a specific quantitative “dose” of exposure, and how courts should evaluate methodological gaps between epidemiologic sources and the ultimate causation opinion.
Case Background and Procedural Posture
Ruffin worked for approximately five months as a shoreline cleanup worker in Louisiana following the 2010 Deepwater Horizon oil spill. He was diagnosed with prostate cancer about five years later and pursued claims under the medical-benefits class action settlement’s Back-End Litigation Option (BELO), which requires proof that “the legal cause of the claimed injury or illness is exposure to oil or other chemicals used during the response.” After discovery, Ruffin designated multiple experts, including a causation expert, Dr. Benjamin Rybicki, a genetic and molecular epidemiologist.
BP moved to exclude Rybicki’s opinions under Federal Rule of Evidence 702 and Daubert. Following a hearing, the district court granted the motion, concluding that the opinions did not identify a harmful level of exposure necessary to cause prostate cancer and did not demonstrate exposure to such a level, and further found an “analytical gap” between the data relied upon and the conclusions offered. With the causation testimony excluded, the court entered summary judgment for BP on the ground that Ruffin could not prove causation. Ruffin appealed, and the Fifth Circuit reviewed the exclusion for abuse of discretion and the summary judgment ruling de novo.
The Expert Causation Theory and the Evidence Offered
Rybicki’s report attributed Ruffin’s prostate cancer to exposure to polycyclic aromatic hydrocarbons (PAHs), which he described as common environmental compounds found in crude oil, among other sources. He highlighted benzo(a)pyrene as the “most prevalent” PAH and opined that at least one PAH compound can cause prostate cancer, citing animal research and occupational studies. Drawing on those sources, Rybicki characterized the association between occupational PAH exposure and prostate cancer as “modest,” estimating an elevated risk in the range of roughly 1.5- to 2-fold.
To connect the literature to Ruffin, Rybicki used a differential etiology framework. He identified Ruffin’s genetic risk as a “first hit,” then considered and discounted other occupational sources, including Ruffin’s two-decade work history as a truck driver, where diesel exhaust could involve PAH exposure but was described as “modest at best.” Rybicki attributed meaningful exposure to two alleged oil-spill incidents: oil splashing onto Ruffin while traveling by boat and Ruffin falling face-first into water while retrieving an oil-saturated boom. Ruffin also described strong petroleum-like fumes, dizziness, headaches, and coughing up black soot, and Rybicki characterized the oil-spill exposure as a “second and necessary hit” initiating the cancer process.
The Fifth Circuit’s Daubert Analysis and General Causation Holding
On appeal, BP argued for an admissibility rule requiring an expert to identify the minimum quantitative dose of a chemical needed to cause the alleged condition. The Fifth Circuit declined to adopt a strict numerical-dose requirement, explaining that its precedent allows general causation opinions supported by evidence of harmful exposure levels expressed in ranges and tied to realistic human exposure scenarios. The court also noted that prior decisions have permitted non-mathematically precise showings, including reliance on toxicological profiles and temporal relationships, so long as the methodology is reliable and fit to the facts.
Even without a hard dose rule, the panel affirmed exclusion because it agreed the testimony failed Daubert’s reliability and “fit” requirements on general causation. The court emphasized that, in toxic-tort cases, the relevant question is whether the chemical the plaintiff was exposed to is capable of causing the specific condition in the general population, and that courts may exclude opinions where “there is simply too great an analytical gap between the data and the opinion proffered.” The panel concluded that Rybicki’s analysis did not reliably support his central assertion that PAHs, as framed in the case, can cause prostate cancer, and that the methodological flaws identified by the district court were fatal. With admissible general causation lacking, the court did not reach specific causation and affirmed summary judgment for BP.
Practical Implications for BELO Toxic-Tort Litigation
The substituted opinion clarifies that, in Fifth Circuit toxic-exposure cases, plaintiffs are not necessarily required to present a single quantified exposure number to satisfy general causation under Rule 702. Instead, expert proof must reliably connect the cited scientific literature to exposure conditions that are plausible for humans in the relevant setting, while maintaining consistency between the chemical(s) analyzed and the chemical(s) allegedly encountered. Where an expert’s reasoning shifts between crude oil exposure and a narrower carcinogenic constituent without a supported bridge, courts may view that mismatch as a reliability problem rather than merely a dispute over weight.
The outcome also reflects the decisive procedural effect of Daubert rulings in BELO claims: exclusion of a causation expert often collapses the plaintiff’s ability to meet the settlement’s causation requirement, making summary judgment likely. According to court filings, BP was represented in the appeal by Gibson Dunn, among other counsel. More broadly, the decision signals continued judicial scrutiny of epidemiologic and occupational-association evidence when an expert seeks to translate “modest” risk signals into case-specific causal conclusions without a clearly articulated, methodologically sound fit.
